Home  >  Products  >  TLX1 (T-cell leukemia homeobox 1) Blocking Peptide (the middle region of protein) (100ug)
TLX1 (T-cell leukemia homeobox 1) Blocking Peptide (the middle region of protein) (100ug)

TLX1 (T-cell leukemia homeobox 1) Blocking Peptide (the middle region of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TLX1 antibody (Catalogue #: P100612_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP30922
Size: 100 ug
Weight: 34kDa
Gene: 3195
Format: Lyophilized powder
Target: TLX1 contains 1 homeobox DNA-binding domain. TLX1 controls the genesis of the spleen. A chromosomal aberration involving TLX1, translocation t(10;14)(q24;q11) with TCRD, may be a cause of a form of T-cell acute lymphoblastic leukemia (T-ALL).
Alternative names: HOX11; MGC163402; TCL3
See Full Product Listings >